Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

被引：9
作者：
Mabuchi, Tomotaka [1 ]
Yamaoka, Hanako [1 ]
Kawai, Mayu [1 ]
Ota, Tami [1 ]
Ozawa, Akira [1 ]
机构：
[1] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan
来源：
JOURNAL OF DERMATOLOGY | 2014年 / 41卷 / 12期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY;
D O I：
10.1111/1346-8138.12681
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1136 / 1137
页数：2
相关论文
共 50 条
  • [41] Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study
    Johan Dalén
    Karin Luttropp
    Axel Svedbom
    Christopher M. Black
    Sumesh Kachroo
    Advances in Therapy, 2020, 37 : 3746 - 3760
  • [42] A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology
    Takamura, Akito
    Hirata, Shintaro
    Nagasawa, Hayato
    Kameda, Hideto
    Seto, Yohei
    Atsumi, Tatsuya
    Dohi, Makoto
    Koike, Takao
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2013, 23 (02) : 297 - 303
  • [43] Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease
    Eder, Lihi
    Joshi, Aditya A.
    Dey, Amit K.
    Cook, Richard
    Siegel, Evan L.
    Gladman, Dafna D.
    Mehta, Nehal N.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (03) : 408 - 416
  • [44] Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-α agent in a psoriatic arthritis patient
    Buccoliero, Giovanni
    Lonero, Gaetano
    Romanelli, Chiara
    Loperfido, Pietro
    Resta, Francesco
    NEW MICROBIOLOGICA, 2010, 33 (03) : 271 - 274
  • [45] Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Eiji Torikai
    Akira Nagano
    Rheumatology International, 2007, 27 : 467 - 472
  • [46] Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Kageyama, Yasunori
    Torikai, Eiji
    Nagano, Akira
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 467 - 472
  • [47] Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis Results of a Randomized Controlled Trial
    Bissonnette, Robert
    Tardif, Jean-Claude
    Harel, Francois
    Pressacco, Josephine
    Bolduc, Chantal
    Guertin, Marie-Claude
    CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (01) : 83 - 90
  • [48] Efficacy of etanercept in rheumatoid arthritis patients and its effects on interleukin-6 and serum tumor necrosis factor ?
    Li, Suihua
    Mei, Qinghua
    Qian, Dan
    Huang, Xianghong
    Fan, Cuimiao
    Quan, Jia
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (01) : 207 - 213
  • [49] Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy
    Pina, Trinitario
    Genre, Fernanda
    Lopez-Mejias, Raquel
    Armesto, Susana
    Ubilla, Begona
    Mijares, Veronica
    Dierssen-Sotos, Trinidad
    Corrales, Alfonso
    Gonzalez-Lopez, Marcos A.
    Gonzalez-Vela, Maria C.
    Blanco, Ricardo
    Hernandez, Jose L.
    Llorca, Javier
    Gonzalez-Gay, Miguel A.
    JOURNAL OF DERMATOLOGY, 2016, 43 (04) : 389 - 394
  • [50] Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
    Mannion, Melissa L.
    Amin, Shahla
    Balevic, Stephen
    Chang, Min-Lee
    Correll, Colleen K.
    Kearsley-Fleet, Lianne
    Hyrich, Kimme L.
    Beukelman, Timothy
    ARTHRITIS CARE & RESEARCH, 2024, 76 (08) : 1090 - 1098
12345